Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELAS PHARMACIE NOUVELLE DE LYON : revenue, balance sheet and financial ratios

SELAS PHARMACIE NOUVELLE DE LYON is a French company founded 10 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75012), this company of category PME shows in 2022 a revenue of 2.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELAS PHARMACIE NOUVELLE DE LYON (SIREN 814662441)
Indicator 2024 2022 2021 2020 2019 2018 2017 2016
Revenue N/C 2 104 302 € N/C N/C N/C N/C N/C N/C
Net income -8 542 € 201 760 € 241 204 € 104 304 € 103 432 € 95 840 € 93 549 € -22 960 €
EBITDA N/C 267 910 € N/C N/C N/C N/C N/C N/C
Net margin N/C 9.6% N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, SELAS PHARMACIE NOUVELLE DE LYON records a net loss of 9 k€. This deficit will reduce equity on the balance sheet.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-8 542 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 469%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 15%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

469.325%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

15.038%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

89.7%

Solvency indicators evolution
SELAS PHARMACIE NOUVELLE DE LYON

Sector positioning

Debt ratio
469.32 2024
2021
2022
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average +34 pts over 3 years

In 2024, the debt ratio of SELAS PHARMACIE NOUVELLE ... (469.32) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
15.04% 2024
2021
2022
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch -35 pts over 3 years

In 2024, the financial autonomy of SELAS PHARMACIE NOUVELLE ... (15.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
1.6 years 2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Good

In 2022, the repayment capacity of SELAS PHARMACIE NOUVELLE ... (1.60) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 207.94. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

207.937

Liquidity indicators evolution
SELAS PHARMACIE NOUVELLE DE LYON

Sector positioning

Liquidity ratio
207.94 2024
2021
2022
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Good -17 pts over 3 years

In 2024, the liquidity ratio of SELAS PHARMACIE NOUVELLE ... (207.94) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
1.43x 2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average

In 2022, the interest coverage of SELAS PHARMACIE NOUVELLE ... (1.4x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELAS PHARMACIE NOUVELLE DE LYON

Positioning of SELAS PHARMACIE NOUVELLE DE LYON in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS PHARMACIE NOUVELLE DE LYON with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS PHARMACIE NOUVELLE DE LYON

What is the revenue of SELAS PHARMACIE NOUVELLE DE LYON ?

The revenue of SELAS PHARMACIE NOUVELLE DE LYON in 2022 is 2.1 M€.

Is SELAS PHARMACIE NOUVELLE DE LYON profitable?

SELAS PHARMACIE NOUVELLE DE LYON recorded a net loss in 2024.

Where is the headquarters of SELAS PHARMACIE NOUVELLE DE LYON ?

The headquarters of SELAS PHARMACIE NOUVELLE DE LYON is located in PARIS (75012), in the department Paris.

Where to find the tax return of SELAS PHARMACIE NOUVELLE DE LYON ?

The tax return of SELAS PHARMACIE NOUVELLE DE LYON is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS PHARMACIE NOUVELLE DE LYON operate?

SELAS PHARMACIE NOUVELLE DE LYON operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.